Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.7300
-0.0143 (-1.92%)
At close: May 12, 2025, 4:00 PM
0.7232
-0.0068 (-0.93%)
After-hours: May 12, 2025, 7:44 PM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $56.82 million as of May 12, 2025. Its market cap has decreased by -2.59% in one year.
Market Cap
56.82M
Enterprise Value
19.52M
1-Year Change
-2.59%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $56.82M, an increase of 26.14%. That is a compound annual growth rate of 5.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 57.93M | -9.76% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |